<span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Search Results

October 16, 2017 News

The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in…

The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in A...

March 5, 2024 Whitepaper

Expertise

Oncology CRO services

The global Oncology landscape for Biotechnology companies...

Precision Oncology Clinical Trials & Statistics 2024

Explore the transformative role of precision oncology in cancer treatment with Novotech CRO's whitepaper....

May 26, 2023 News

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

Chicago, IL USA - Novotech, the leading Asia Pacific centred biotech CRO is spon...

July 14, 2020 Webinar

Advancing oncology trials in Asia-Pacific

A growing number of biotechnology companies are looking at the Asia-Pacific region to run their clinical trials in oncology…

March 14, 2024 News

Novotech Publishes Precision Oncology Landscape Whitepaper Identifying Current Trends and…

Boston, USA - Novotech, the global full-service clinical Contract Resea...

May 20, 2022 Webinar

Development and Regulatory Strategy for US and China

This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers…

August 27, 2019 Case Study

Biotechnology company looking for Oncology CRO services. Regulatory and recruitment expertise…

The Background When South Korean oncology biotechnology company PharmAbcine completed a successful domestic phase I study...

December 10, 2024 Webinar

Clinical Trials and the Evolving Global Standard of Care in Precision Oncology

This webinar will address the critical global disparities in the standard of care for precision medicine, focusing on access to…

June 6, 2022 News

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in…

Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has rec...

June 2, 2022 News

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and…

Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded it...

June 7, 2022 Webinar

Accelerating clinical development in China & the US

China and the US are the world’s largest oncology research destinations, and the clinical research bridge between them supports…

December 21, 2022 News

Novotech Sponsors “The Next Big Thing in Cancer Care” Webinar - CAR-T, Precision Oncology, AI and…

Novotech, the Asia Pacific centered biotech specialist CRO, presents “The Next Big Thing in Cance...

April 13, 2023 News

Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer…

Novotech, the leading Asia Pacific centred biotech CRO joins oncology leaders at the eChinaHealth...

June 5, 2023 Webinar

Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from…

What ways are we innovating CAR-T, ADCs, Immunotherapies, and mRNAs as they wind their way through the pipeline and beyond? How…

May 13, 2022 Webinar

Go/No Go Decisions Based on Early Phase Oncology Trials

Understanding the latest regulatory and clinical developments in the field of Oncology in China, along with discussing the…

September 5, 2022 News

Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC

Meet the team at Booth #409 ...

October 7, 2022 News

Featured in the endpoints news- the factors driving a rapid evolution of gene & cell therapy and…

APAC is the fast growing region globally for cell & gene therapy trials representing...

May 22, 2020 News

New research shows high continuity at clinical sites in Asia-Pacific for oncology studies

New research conducted by the Cancer Research Institute suggested oncology clinical research site...

November 15, 2019 News

Asia-Pacific shows higher patient recruitment rates for Oncology clinical trials

Biotechnology companies are facing tremendous challenges around...

August 25, 2019 Case Study

Rescue study and Oncology CRO services. Local know-how gets pivotal breast cancer trial back on…

The Background When recruitment for a global breast cancer trial was lagging, Novotech was engaged as the Asia Pacific regional...

November 15, 2024 Case Study

Indian Biotech Phase IIB

BackgroundA biotech company based in India embarked on a Phase IIb clinical trial t...

November 20, 2019 News

Novotech discusses biotechnology CRO services at leadership meeting in Malaysia

Novotech is a full service CRO, offering CRO services across all the Asia-Pacific region with ope...

January 9, 2025 Whitepaper

Oncolytic Virus Therapy Clinical Trials Global Landscape Whitepaper 2024

Download the Comprehensive Guide on Global Oncolytic Virus Therapy Clinical Trials...

February 26, 2025 Blog

What Is FDA’s Project Optimus and How Does It Impact Clinical Trials?

Project Optimus is an initiative by the U.S....

March 14, 2023 News

Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report

Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published...

September 29, 2017 News

Webinar - Navigating Oncology Trials in Asia: How a Regional CRO can Deliver on a Global Project

Almost half of these occur in Asia with almost one quarter of the global burden in China....

January 23, 2023 Webinar

The Next Big Thing in Cancer Care

Novotech, the Asia Pacific centered biotech specialist CRO, presents “The Next Big Thing in Cancer Care” expert panel webinar in…

July 26, 2024 Webinar

Current Status and Prospects of Advanced Therapies in China

This webinar will provide you with an overview of the progress and future of advanced therapies in China.

March 26, 2024 FAQ

Global Prevalence and Clinical Trials Landscape of Acute Myeloid Leukaemia

Acute Myeloid Leukaemia is a malignant blood disorder primarily affecting adults, with low survival rates and various risk factors including...

May 13, 2024 Report

Endometrial cancer - Global Clinical Trial Landscape (2024)

Explore cutting-edge endometrial cancer research with Novotech CRO's disease report....

September 5, 2023 Whitepaper

Rare Disease – Global Clinical Trial Landscape (2018-2022)

Exploring the Rare Diseases Global Clinical Trials Landscape: Unveiling Challenges, Trends, and Promising Adv...

November 20, 2024 News

Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology…

Novotech, the global full-service clinical Contract Research Organization (CRO...

September 2, 2022 News

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a repor...

September 13, 2023 FAQ

Rare Disease Clinical Trials: Unveiling Insights and Charting Progress

A rare disease, as defined by the WHO, is one that affects fewer than one person in every 1,000 and...

October 5, 2017 News

Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO

The announcement was made at the ASCO Annual Meeting (May 31 - June 4, 2019 McCormick Place...

May 21, 2024 FAQ

Unveiling the Potential of Antibody-Drug Conjugates

This FAQ section explores key trends in clinical trials, applications, and cutting-edge research shaping the future of these targeted therapies....

January 6, 2020 News

Immuno-Oncology clinical trial landscape in Asia-Pacific

A growing number of biotechnology companies are looking at Asia and Australia to run their ...

October 16, 2024 Report

Bladder Cancer: Global Clinical Trial Landscape (2024)

Explore cutting-edge bladder cancer research with Novotech CRO's disease report. Learn about new treatments, clinical trials, and future innovations in...

February 11, 2021 News

Celebrating International Day for Women and Girls in Science 2021

Thursday 11 February 2021...

April 29, 2025 Blog

Top Biotech Hubs Around the World: Where Innovation Thrives in 2025

Biotech hubs across the globe are driving scientific breakthroughs, fueling investment, and transform...

December 10, 2024 Blog

What Are Hybrid Clinical Trials? Why They Became the Preferred Model in 2024

What is a hybrid clinical trial?...

November 18, 2024 News

Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung…

October 2024 – Novotech, the global full-service clinical Contract Research Orga...

November 15, 2024 News

The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research

November 2024 – Novotech, the global full-service clinical Contract Research Organizatio...

January 13, 2025 News

Novotech Releases Comprehensive Report on Oncolytic Virus Therapy

Sydney, Australia – December 2024 Novotech, the global full-s...

November 12, 2024 News

Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners wit...

April 4, 2023 Blog

The Cell & Gene Therapy Clinical Trials Global Landscape

Cell & gene therapies have emerged as revolutionary treatments for a variety of diseases, including cancer, genet...

February 2, 2023 News

Greater China

At more than 1.4 billion people, China is the world’s most populated country, with an increasing...

Asia Pacific Cell & Gene Research Growing 50% Faster than ROW

Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the...

July 12, 2024 News

New Report Highlights Global Trends and Advances in Chronic Lymphocytic Leukemia Research and…

Boston, USA – Novotech, the global full-service clinical Contract Resea...

March 26, 2021 Webinar

Asia Pacific: The solution for accelerating your clinical trial program

Presented By Katrina Norial at OCT Southeast. In this presentation Katrina Norial discusses Novotech’s capabilities, ensuring…

June 26, 2024 FAQ

Insights into Non-Small Cell Lung Cancer: Global Clinical Research Overview

Non-small cell lung cancer (NSCLC), which constitutes about 85% of all lung cancers originates from larger cells, such as the...

January 8, 2025 FAQ

FAQs on the Oncolytic Virus Therapy: Insights into Clinical Trial Landscape and Industry Trends

Explore our comprehensive FAQs addressing critical aspects of oncolytic virus therapy, including clinical trial trends, therapeutic advancements, delivery innovations, and...

November 14, 2024 News

Global Cell and Gene Therapy Trials: Driving Innovation in Oncology and Beyond

Novotech, the global full-service clinical Contract Research Organization (CRO), has published it...

May 21, 2024 Webinar

Transitioning from Healthy Volunteers to Patients: Navigating the Clinical Development Journey

As you embark on Phase 2 after successfully launching your Phase 1 healthy volunteer study in Australia or New Zealand, it’s time…

June 28, 2024 News

Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines…

Boston, USA - Novotech, the global full-service clinical Contract Resea...

March 26, 2025 Article

Bladder Cancer: Challenges, Innovations, and Opportunities for Primary Care Physicians

In a recent article from Medical Economics, Sarah Anderson, Novotech’s Therapeutic Strategy Lead – Oncology, outlines the evolv...

February 3, 2025 Blog

Why New Zealand Is Emerging as a Clinical Trial Hub

Is New Zealand a rising destination for clinical trials?...

August 27, 2024 Report

Pancreatic Cancer: Global Clinical Trial Landscape (2024)

Explore cutting-edge pancreatic cancer research with Novotech CRO's disease report....

October 3, 2024 Report

Diffuse Large B-Cell Lymphoma- Global Clinical Trial Landscape (2024)

Explore the latest advancements in diffuse large B-cell lymphoma with Novotech CRO's comprehensive disease landscape analysis....

October 1, 2024 Report

Small Cell Lung Cancer: Global Clinical Trial Landscape (2025)

Explore the evolving treatment landscape for small cell lung cancer through Novotech CRO’s latest disease report....

January 7, 2025 Report

Triple-Negative Breast Cancer: Global Clinical Trial Landscape (2024)

Discover the latest advancements in triple-negative breast cancer through Novotech CRO's in-depth disease analysis....

August 15, 2024 FAQ

RNA Therapies – Global Clinical Trials Landscape (2024)

Comprehensive FAQs on RNA Therapies: Insights into Clinical Trials Landscape and Industry Trends...

September 20, 2024 Report

Cervical Cancer - Global Clinical Trial Landscape (2024)

Explore cutting-edge research in cervical cancer with Novotech CRO's disease report....

June 24, 2024 Report

Non-Small Cell Lung Cancer - Global Clinical Trial Landscape (2024)

Discover the latest advancement in Non-Small Cell Lung Cancer research through Novotech CRO's in-depth disease analysis....

August 22, 2024 Report

Gastric Cancer- Global Clinical Trial Landscape (2024)

Discover the latest advancement in gastric cancer through Novotech CRO's in-depth disease analysis....

June 19, 2024 Report

Liver Cancer - Global Clinical Trial Landscape (2024)

Explore cutting-edge liver cancer research with Novotech CRO's disease report. Learn about new treatments, clinical trials, and future innovations in...

March 3, 2023 News

Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends

Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trial...

July 11, 2024 Report

Oesophageal Cancer: Global Clinical Trial Landscape (2024)

Explore cutting-edge oesophageal cancer research with Novotech CRO's disease report....

March 26, 2024 Report

Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)

Discover the latest advancements in Acute Myeloid Leukaemia research through Novotech CRO's comprehensive disease report....

February 10, 2023 News

Global Report: Robust Phase 1 Trial Growth Across Asia Pacific

Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phas...

April 1, 2022 FAQ

Clinical Trends of 2022

2022 marks the third year of the worldwide COVID-19 pandemic, which continues to fuel the transformation of the clinical trial...

August 15, 2024 Whitepaper

RNA Therapy Clinical Trials Whitepaper – 2024

Explore the future of RNA therapeutics with Novotech's comprehensive whitepaper....

September 25, 2020 Webinar

Accelerating Clinical Trials in Australia and Asia – Presented by Steven Roan at OCT USA

Steven Roan breaks down the acceleration of clinical trials in Australia and Asia. The presentation is broken into three main…

March 27, 2024 Webinar

Ready for January 2025? Roadmap to CTIS compliance

As Europe bids farewell to EudraCT after nearly two decades, it welcomes the Clinical Trial Information System (CTIS) as the new…

October 30, 2023 Whitepaper

Navigating The Biotech Landscape: Insights Into Clinical Trials, Funding Trends, Challenges, And…

Biotech Layoffs 2023: Evolving Landscape & Funding Analysis...

April 15, 2024 News

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical…

Boston, USA - Novotech, the global full-service clinical Contract Resea...

May 21, 2024 Whitepaper

Comprehensive Report on Antibody-Drug Conjugates Clinical Trials 2024

Download the 2024 clinical trial report on Antibody-Drug Conjugates, covering new drug developments and market insigh...

June 19, 2024 FAQ

Insights into Radiopharmaceuticals: Global Clinical Research Overview

Explore key insights and emerging trends in the field of radiopharmaceuticals from our 2024 clinical trial landscape white paper, answering...

January 9, 2024 News

Early-Stage Biotech Investments Were Down 40% in 2023: Novotech Whitepaper

Boston, USA - Novotech, the leading Asia...

April 5, 2023 Report

Prostate Cancer Global Clinical trial landscape - Focus on Asia Pacific

In 2020, Asia accounted for more than a quarter of worldwide Prostate cancer incidence cases, with China and Japan together...

September 4, 2024 FAQ

Overview of Gastric Cancer: Global Clinical Trial Landscape

Gastric cancer ranks as the fifth most diagnosed cancer and the leading cause of cancer-related deaths....

August 28, 2023 Report

Gallbladder Cancer: Global Clinical Trial Landscape

Gallbladder cancer develops when malignant cells proliferate in the mucosal layer of the gallbladder and expand outward....

November 13, 2024 News

Novotech releases In-Depth Report on Cervical Cancer: Addressing a Global Health Challenge

Boston, USA – Novotech, the global full-service clinical Contract Research Organization (CRO), ha...

March 31, 2022 Report

Triple negative breast Cancer

With a high population density and over 45% of the global breast cancer incidence, Asia is expected to account for...

November 22, 2022 News

Oncoshot and Novotech Partner to Offer Cancer Data Insights

SINGAPORE, October 2022 /PRNewswire/ -- Oncoshot and internationally recognised contract research...

July 31, 2024 News

In-Depth Report on Global Oesophageal Cancer Clinical Trials Now Available

San Francisco, CA – Novotech, the global full-service clinical Contract Research...

May 26, 2023 Report

Non-Hodgkin Lymphoma Global Clinical trial Landscape- Focus on Asia Pacific

Asia accounted for more than 40% of the world's Non-Hodgkin Lymphoma incidence in 2020, with China contributing the majority....

October 1, 2024 FAQ

Overview of Small Cell Lung Cancer: Global Clinical Trials Landscape

Small cell lung cancer is a fast-growing and aggressive subtype of lung cancer, accounting for approximately 10-15% of all lung...

November 29, 2021 Report

Colorectal cancer clinical trials landscape asia pacific

The incidence of colorectal cancer cases is rapidly growing in Asia-Pacific and the region now accounts for more than half...

August 5, 2022 Whitepaper

Immuno-oncology – Asia pacific – clinical Trial landscape

Asia Pacific has shown significant increase in Immuno-oncology trials between 2017 and 2021 and contributes to more than a third...

July 10, 2024 FAQ

Insights into Chronic Lymphocytic Leukemia: Global Clinical Research Overview

Chronic Lymphocytic Leukemia (CLL) is slow-growing leukemia characterized by a progressive accumulation of functionally impaired B lymphocytes of monoclonal origin....

April 28, 2023 Report

Ovarian Cancer - Global Clinical trial landscape- Focus on Asia Pacific

Asia accounted for more than half of the global Ovarian Cancer incidence cases in 2020, with majority of them contributed...

September 27, 2024 FAQ

Cervical Cancer– Global Clinical Trials Landscape (2024)

Comprehensive Frequently Asked Questions on cervical cancer: Insights into Clinical Trial Landscape and Industry Trends....

July 13, 2022 Report

Multiple myeloma - Asia pacific – clinical Trial landscape

Multiple myeloma cases are increasing in Asia, with the region currently contributing to more than 35% of the projected global...

June 28, 2024 News

Novotech Publishes Report on Research into Endometrial Cancer, a Leading Cause of Gynecology…

Boston, USA – Novotech, the glo...

April 6, 2023 Report

Breast Cancer- Global Clinical Trial Landscape- Focus on Asia Pacific

Asia accounted for approximately 45% of the global breast cancer cases in 2020, with Mainland China, India, and Japan contributing...

September 5, 2024 News

Novotech Releases 2024 Report on Pancreatic Cancer Clinical Trials and Drug Development

Boston, USA – Novotech, the global full-service clinical Contract Research Organ...

May 24, 2022 Report

Renal Cell Carcinoma

Owing to its large population base, Asia accounts for over 35% of the estimated global incidence of Renal cell carcinoma,...

May 15, 2024 FAQ

Overview of Endometrial cancer: Global Clinical Trials Landscape

Uterine cancer, primarily endometrial cancer, ranks as the fourth leading cause of global gynecological malignancy-related deaths....

January 7, 2025 FAQ

Overview of Triple-Negative Breast Cancer: Global Clinical Trial Landscape

Triple-Negative Breast Cancer (TNBC) is a highly aggressive and heterogeneous subtype of breast cancer ...

March 2, 2023 Whitepaper

Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific

Asia Pacific has been the fastest growing region in multi-specific monoclonal antibody trials since 2018, with the re...

September 4, 2024 FAQ

Overview Of Pancreatic Cancer: Global Clinical Trials Landscape

Pancreatic cancer is one of the deadliest gastrointestinal cancers, ranking twelfth in global incidence and sixth in cancer-related deaths....

September 1, 2023 Report

Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

Nasopharyngeal carcinoma is the most common cancer originating from the nasopharyngeal epithelium and is often undifferentiated. It is mainly found...

October 24, 2024 FAQ

Overview of Bladder Cancer: Global Clinical Trials Landscape

Bladder cancer is the ninth most common cancer globally and ranks thirteenth in mortality....

January 21, 2022 Report

Thyroid cancer

Asia accounted for almost 60% of the global incidence, mortality and five-year prevalence in 2020, with the highest incidence rates...

September 29, 2022 Report

Bile duct cancer (Cholangiocarcinoma) Asia Pacific – Clinical Trial Landscape

Asia has a significantly greater prevalence of Cholangiocarcinoma, in comparison to the other parts of the world, with China, South...

July 18, 2024 FAQ

Overview of Oesophageal cancer: Global Clinical Trials Landscape

Oesophageal cancer is the 11th most diagnosed cancer and the 7th leading cause of cancer mortality. It starts in the...

June 2-6, 2023 Events

ASCO Annual Meeting (In Person)

Chicago

October 2, 2024 FAQ

Overview of Diffuse large B-cell lymphoma: Global Clinical Trial Landscape

Diffuse large B-cell lymphoma is the most common and aggressive subtype of non-Hodgkin lymphoma....

July 27, 2022 Report

Solid tumors - Asia Pacific – Clinical trial Landscape

There were over 8.2 million new cases and over 5 million deaths due to solid cancers in Asia, with the...

July 5, 2024 News

Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally

Boston, USA – Novotech, a global full-service clinical Contract Researc...

April 27, 2023 Report

Melanoma - Global Clinical trial landscape- Focus on Asia Pacific

Asia contributed close to 24,000 melanoma cases in 2020, with Australia and New Zealand having the highest incidence rates in...

September 6, 2024 News

Novotech Unveils 2024 Report on Global Gastric Cancer Clinical Trials and Cutting-Edge Therapeutics

Boston, USA – Novotech, the global full-service clinical Contract Research Organ...

May 26, 2022 Whitepaper

Next Generation Sequencing

NGS profiling improves patient outcomes while also lowering treatment costs and time to diagnosis for cancer patients...

June 19, 2024 FAQ

Overview of Liver Cancer: Global Clinical Trials Landscape

Liver cancer is the sixth most diagnosed cancer globally and the third leading cause of cancer death....

January 7, 2025 News

Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials

Sydney, Australia – Novotech, the leading global full-service clinical Contract...

March 27, 2025 News

Novotech Report Reveals Growth in siRNA Research: Over 150 Industry-Sponsored Clinical Trials…

Sydney, March 2025 – Novotech, a globally recognized full-ser...

Clinical Research Associate (CRA) Essentials Program

JANUARY 2022 INTAKE – AUSTRALIA AND NEW ZEALAND We are internationally recognized as a leading regional ful...

New Zealand

Importantly, New Zealand also offer alternative recruitment potential to northern hemisphere seas...

April 22, 2025 Article

Speed of China’s early clinical trials raises bar for Western biotechs

China’s rapid-fire approach to early-stage clinical trials is redefining global drug development standards....

January 2023 Intake - Malaysia ...

Philippines

The Philippines is the world’s 12th most populous country, with a growing, newly industriali...

December 20, 2023 Case Study

Progressing from Single Country Phase I Success to Securing a Multinational Phase I/II Clinical…

Background In Search of a Strategic Partnership...

April 9-10, 2025 Events

Oncology Site Solutions Summit 2025

Atlanta, Georgia

March 19, 2025 Whitepaper

Optimizing siRNA Therapeutics: Addressing Nonclinical and Manufacturing Complexities

Recent FDA approvals of siRNA drugs have revolutionized drug development for this therapeutic modality, which leverag...

January 8, 2016 News

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals...

Associate Project Manager Program

JANUARY 2022 INTAKE – AUSTRALIA...

December 23, 2023 Case Study

Expert Consulting and Multi-Regional Clinical Trial (MRCT) Strategy Rescues Oncology Program

Background A biotech sponsor based in China with a focus on innovating novel immunotherapy treatments, encountered...

April 24, 2020 News

Biotechnology Companies Turning to Asia-Pacific for Clinical Trials During North America Slowdown.

Biotechnology sponsors are attracted to the region because sites ha...

Expertise

Clinical and Regulatory Strategy

Clinical and Regulatory Strategy: Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of...

May 31, 2013 News

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in…

Imugene’s clinical review for HER-Vaxx is now complete HER-Vaxx Phase 1b/2 in ga...

January 13, 2020 News

South Korea

South Korea has a population of 51 million, offers world-class infrastructure and is fast becomin...

Asia-Pacific has record year for clinical trials according to Novotech

San Francisco, CA – Novotech the largest biotech CRO in the Asia-Pacific sa...

July 5, 2011 News

NOVOGEN ENGAGES CONTRACT RESEARCH ORGANISATION TO CONDUCT CANTRIXIL PHASE 1 CLINICAL TRIAL

Sydney, November 24, 2015 - US-Australian drug discovery company, Novogen Limited (ASX:NRT: NASDA...

November 9, 2021 News

Novotech Platinum Sponsor at ChinaTrials13 Summit Shanghai 2021

Sydney - Novotech, a leading biotech specialist CRO in the Asia-Pacific region,...

March 8-9, 2024 Events

Australian Precision Oncology Symposium (APOS)

Sydney, Australia

June 28, 2024 News

Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World…

Boston, USA-Novotech, the globa...

August 31, 2009 News

NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION

NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION...

ASCO Annual Meeting & BIO International Convention

...

January 29, 2019 News

Novotech Update: South Korea to cover standard of care for patients participating in clinical trials

In a recent update, South Korea’s National Health Insurance Program outlined plans to also cover...

October 25, 2022 Whitepaper

The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval

Global biopharma companies are looking to capitalize on value creation across different geographic regions through ut...

August 28, 2023 FAQ

Advancing Treatment of Gallbladder Cancer (GBC): Clinical Trials, New Drugs, and Innovative Strategies

GBC presents unique challenges due to its often-advanced stage at diagnosis....

September 13, 2023 FAQ

Unlocking the Future of Healthcare: Exploring Global Clinical Trends in Cell & Gene Therapy

Cell and gene therapy (CGT) is one of the most advanced areas of medicine that can effectively transform our own...

November 26, 2024 News

Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners wit...

January 9, 2024 News

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs…

San Francisco, CA, USA -...

July 14, 2022 News

Novotech’s APAC and USA Leadership Teams at BIO 2022

San Diego - USA - Novotech, the leading Asia Pacific biotech specialist CRO whic...

October 27, 2022 FAQ

Contract Research Organisations: Market and Trends

The Contract Research Organisation (CRO) industry is constantly changing and growing due to various key factors like a growing healthcare...

June 15, 2020 News

Novotech Partners with South Korea’s 1,300-bed Pusan National University Hospital

The leading Asia-Pacific biotech specialist CRO Novotech&n...

July 29, 2020 FAQ

How CRO Companies Work? - A Basic Overview

It’s quite common for pharmaceutical and biotechnology companies introducing new drugs and treatment to outsource trials of new medication or...

October 5, 2023 News

Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services

BOSTON, Oct....

June 30, 2022 News

Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022

Seoul, South Korea - Novotech, the leading Asia Pacific biotech specialist CRO w...

May 26, 2022 News

Novotech Acquires US CRO - Expands Global Expertise

Singapore and Charleston, SC - Novotech, the leading Asia-Pacific...

May 10, 2014 News

Novotech announces four country Asia expansion at AusBiotech 2009

October 27, 2009...

October 13, 2023 News

Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr…

Boston, USA, 12 October 2023 - Novotech, the leading Asia Pacific centred biotec...

May 5, 2025 Blog

What Is the Role of CROs in Drug Development?

Contract Research Organizations (CROs) play a pivotal role in accelerating drug development, optimizi...

December 10, 2019 News

Solution

Site Management Organization (SMO)

Novotech CRO sees changing landscape in Hemato-Oncology at ASH 2019

Novotech, the Asia-Pacific CRO, attends the American Society of Hematology conference in Orla...

July 19, 2022 Webinar

Evolution of cell & gene therapy in China: the case for universal CAR-T

China now represents 60% of clinical development in CAR-T therapy development globally: what have we learned to date and where…

April 9, 2020 News

Novotech selected for new COVID-19 Clinical Trial in Asia-Pacific

Novotech has been engaged by Revive Therapeutics Lt...

August 12, 2020 Webinar

Running First-in-human and Vaccines Studies in Australia

A US Investigational New Drug (IND) submission is not necessary to initiate first-in-human clinical trials in Australia. FIH…

March 24, 2025 FAQ

FAQs: The Early Phase Australian Advantage for Biotech Companies

Australia offers a rare combination of regulatory efficiency, cost savings, high-quality clinical infrastructure, and global data acceptance, making it an...

March 19, 2025 FAQ

FAQs on the siRNA Therapeutics

1. What are siRNA therapeutics, and how do they work?siRNA therapeutics belong to a class of gene-silencing drugs that utilize...

November 18, 2024 FAQ

FAQs on the Global Vaccine Clinical Trial Landscape

Your Questions Answered: Prophylactic vs. Therapeutic Trials, Regional Insights, and Technological Advancements...

November 22, 2019 News

Novotech’s Clinical Network Services wins GENE Awards for Industry excellence in biotech drug…

Clinical Network Services, a subsidiary of Novotech, the Asia-Pacific CRO, was awarded a prestigi...

July 25, 2022 News

Novotech’s Flexible Work Policy is Finalist in Best Workplace Flexibility Program “Excellence Award…

Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has b...

October 22, 2021 Webinar

Driving efficiencies through virtual trial solutions in Asia Pacific

What is driving the acceleration of clinical trials in the Asia Pacific region and what are key considerations to maximise the…

August 28, 2024 News

Transforming the future of medicine with RNA-based therapies

New Novotech Whitepaper Explores Innovations and Impact of this precise, versatile and sc...

November 24, 2023 Whitepaper

Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

Explore the latest trends in immune checkpoint inhibitors clinical trials....

November 29, 2023 FAQ

From Breakthroughs to Challenges: A Comprehensive Exploration of Immune Checkpoint Inhibitors in Cancer Therapy

The landscape of cancer treatment has witnessed a revolutionary transformation with the advent of immune checkpoint inhibitors (ICIs), marking a...

July 10, 2024 Report

Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024)

Discover the latest advancement in Chronic Lymphocytic Leukemia research through Novotech CRO's in-depth disease analysis....

April 10, 2025 Report

Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Idiopathic Pulmonary Fibrosis through Novotech CRO's in-depth disease analysis....

June 22, 2022 News

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

Chicago - USA - Novotech, the leading Asia Pacific biotech specialist CRO which...

September 24, 2021 News

Regional Lead CRA

THE NEXT STEP IN YOUR CLINICAL RESEARCH CAREER If you have passion for the clinical ope...

June 19, 2024 Whitepaper

Radiopharmaceutical Therapy Innovations & Global Clinical Trial Insights 2024

Explore the Latest Innovations, Clinical Trials, and Future Directions in Radiopharmaceuticals...

March 25, 2025 Blog

The Australian Advantage: Why Biotechs Should Leverage Australia's Clinical Research Ecosystem

As the global biotech industry becomes increasingly competitive, emerging and established companies alike are seeking...